0001562180-20-005657.txt : 20200825
0001562180-20-005657.hdr.sgml : 20200825
20200825191921
ACCESSION NUMBER: 0001562180-20-005657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200824
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diamond Andrew S
CENTRAL INDEX KEY: 0001800611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39203
FILM NUMBER: 201133860
MAIL ADDRESS:
STREET 1: C/O 1LIFE HEALTHCARE, INC.
STREET 2: ONE EMBARCADERO CENTER, SUITE 1900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 1Life Healthcare Inc
CENTRAL INDEX KEY: 0001404123
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760707204
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
BUSINESS PHONE: (415) 814-0927
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
FORMER COMPANY:
FORMER CONFORMED NAME: 1life Healthcare Inc
DATE OF NAME CHANGE: 20070621
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-08-24
false
0001404123
1Life Healthcare Inc
ONEM
0001800611
Diamond Andrew S
C/O 1LIFE HEALTHCARE, INC.
ONE EMBARCADERO CENTER, SUITE 1900
SAN FRANCISCO
CA
94111
false
true
false
false
Chief Medical Officer
Common Stock
2020-08-24
4
M
false
15677.00
4.37
A
124651.00
D
Common Stock
2020-08-24
4
S
false
15677.00
29.9931
D
108974.00
D
Stock Option (Right to Buy)
4.37
2020-08-24
4
M
false
15677.00
0.00
D
2019-10-01
2025-09-30
Common Stock
15677.00
27922.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan with shares of common stock received upon concurrent exercises of stock options.
This transaction was executed in multiple trades at prices ranging from $29.99 to $30.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Matthew B. Hemington, Attorney-in-Fact for Andrew S. Diamond
2020-08-25